Allison Swartz, Executive Vice President and General Counsel of Progyny, Inc., filed a Form 4 on November 4, 2026, disclosing the acquisition of 8,160 restricted stock units and 11,370 stock options on November 2, 2026.

Key Highlights

  • RSU grant: Swartz acquired 8,160 shares of common stock underlying restricted stock units at a price of $0 on November 2, 2026.
  • Stock option grant: Swartz also acquired 11,370 stock options with an exercise price of $29.41, expiring November 2, 2036.
  • Post-transaction ownership: Following the RSU grant, Swartz directly holds 83,976 shares of common stock beneficially owned.
  • Vesting schedule: Both the RSUs and stock options vest 33% on March 2, 2027, with the remainder vesting quarterly in equal installments through March 2, 2029, subject to continued service.
  • Reporting person role: Swartz is identified in the filing as EVP, GC (Executive Vice President, General Counsel) of Progyny, Inc., listed on NASDAQ:PGNY.

Swartz RSU and Option Awards at Progyny: Transaction Detail

According to the Form 4 filed with the SEC on November 4, 2026, Allison Swartz, EVP and General Counsel of Progyny, Inc. (NASDAQ:PGNY), reported two equity awards granted on November 2, 2026. The first is a grant of 8,160 restricted stock units, each representing a contingent right to receive one share of Progyny common stock. The filing states these were acquired at a price of $0, and following this transaction Swartz directly holds 83,976 shares of common stock beneficially owned.

The second award consists of 11,370 stock options (rights to buy common stock) at an exercise price of $29.41, with an expiration date of November 2, 2036, also acquired at a price of $0. The filing reports that Swartz directly holds 11,370 derivative securities following this transaction. Both awards are reported as direct holdings and were filed by one reporting person.

The filing explains that both the RSUs and the stock options follow the same vesting structure: 33% shall vest on March 2, 2027, with the remainder vesting quarterly in equal installments thereafter through March 2, 2029, in each case subject to Swartz's continued service on each applicable vesting date. The Form 4 was signed by Mark Livingston as Attorney-in-Fact on November 4, 2026.

What Was Disclosed

Progyny, Inc. EVP and General Counsel Allison Swartz disclosed the receipt of 8,160 RSUs and 11,370 stock options on November 2, 2026, both subject to a vesting schedule running through March 2, 2029, with post-transaction direct beneficial ownership of 83,976 common shares.